203 related articles for article (PubMed ID: 35728766)
1. Topical VX-509 attenuates psoriatic inflammation through the STAT3/FABP5 pathway in keratinocytes.
Yan B; Liu P; Yi X; Li J; Liu N; Zhu W; Kuang Y; Chen X; Peng C
Pharmacol Res; 2022 Aug; 182():106318. PubMed ID: 35728766
[TBL] [Abstract][Full Text] [Related]
2. Perillyl alcohol inhibits keratinocyte proliferation and attenuates imiquimod-induced psoriasis like skin-inflammation by modulating NF-κB and STAT3 signaling pathways.
Sudha Yalamarthi S; Puppala ER; Abubakar M; Saha P; Challa VS; Np S; Usn M; Gangasani JK; Naidu VGM
Int Immunopharmacol; 2022 Feb; 103():108436. PubMed ID: 34929480
[TBL] [Abstract][Full Text] [Related]
3. Periplogenin induces necroptotic cell death through oxidative stress in HaCaT cells and ameliorates skin lesions in the TPA- and IMQ-induced psoriasis-like mouse models.
Zhang WJ; Song ZB; Bao YL; Li WL; Yang XG; Wang Q; Yu CL; Sun LG; Huang YX; Li YX
Biochem Pharmacol; 2016 Apr; 105():66-79. PubMed ID: 26850986
[TBL] [Abstract][Full Text] [Related]
4. WB518, a novel STAT3 inhibitor, effectively alleviates IMQ and TPA-induced animal psoriasis by inhibiting STAT3 phosphorylation and Keratin 17.
Ti C; Chen H; Zhou W; Bian A; Hu P; Miao Y; Shao T; Liu M; Chen Y; Yi Z
Int Immunopharmacol; 2024 Jan; 127():111344. PubMed ID: 38086269
[TBL] [Abstract][Full Text] [Related]
5. DGT, a novel heterocyclic diterpenoid, effectively suppresses psoriasis via inhibition of STAT3 phosphorylation.
Bian G; Wang L; Xie Q; Wang Y; Feng H; Yu Y; Chen Z; Deng S; Li Y
Br J Pharmacol; 2021 Feb; 178(3):636-653. PubMed ID: 33140855
[TBL] [Abstract][Full Text] [Related]
6. Unconjugated bilirubin and its derivative ameliorate IMQ-induced psoriasis-like skin inflammation in mice by inhibiting MMP9 and MAPK pathway.
Bharatha M; Nandana MB; Praveen R; Nayaka S; Velmurugan D; Vishwanath BS; Rajaiah R
Int Immunopharmacol; 2024 Mar; 130():111679. PubMed ID: 38377853
[TBL] [Abstract][Full Text] [Related]
7. Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model.
Palombo R; Savini I; Avigliano L; Madonna S; Cavani A; Albanesi C; Mauriello A; Melino G; Terrinoni A
Cell Death Dis; 2016 Aug; 7(8):e2344. PubMed ID: 27537526
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of JAK1/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model.
Tang J; Liu C; Liu S; Zhou X; Lu J; Li M; Zhu L
Eur J Pharmacol; 2022 Oct; 933():175276. PubMed ID: 36130639
[TBL] [Abstract][Full Text] [Related]
9. Dietary olive oil intake aggravates psoriatic skin inflammation in mice via Nrf2 activation and polyunsaturated fatty acid imbalance.
Donato-Trancoso A; Correa Atella G; Romana-Souza B
Int Immunopharmacol; 2022 Jul; 108():108851. PubMed ID: 35588658
[TBL] [Abstract][Full Text] [Related]
10. [Effect of fire needling on imiquimod induced psoriasis-like lesion and STAT3 pathway in mice].
Feng F; Wang Y; Zhao JX; Di TT; Meng YJ; Chen ZX; Qi C; Hu XQ; Wang YZ; Li P
Zhongguo Zhen Jiu; 2022 May; 42(5):541-8. PubMed ID: 35543945
[TBL] [Abstract][Full Text] [Related]
11. Decreased HMGCS1 inhibits proliferation and inflammatory response of keratinocytes and ameliorates imiquimod-induced psoriasis via the STAT3/IL-23 axis.
Chen L; Huang D; Huang Z; Liu X; He M; Luo M; Tang Z; Tan G; Guo Q; Xiong H
Int Immunopharmacol; 2024 May; 133():112033. PubMed ID: 38608446
[TBL] [Abstract][Full Text] [Related]
12. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
13. Keratinocyte FABP5-VCP complex mediates recruitment of neutrophils in psoriasis.
Hao J; Yu J; Yorek MS; Yu CL; Pope RM; Chimenti MS; Xiong Y; Klingelhutz A; Jabbari A; Li B
Cell Rep; 2023 Nov; 42(11):113449. PubMed ID: 37967009
[TBL] [Abstract][Full Text] [Related]
14. Psoriatic inflammation enhances allergic airway inflammation through IL-23/STAT3 signaling in a murine model.
Nadeem A; Al-Harbi NO; Ansari MA; Al-Harbi MM; El-Sherbeeny AM; Zoheir KMA; Attia SM; Hafez MM; Al-Shabanah OA; Ahmad SF
Biochem Pharmacol; 2017 Jan; 124():69-82. PubMed ID: 27984001
[TBL] [Abstract][Full Text] [Related]
15. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
[TBL] [Abstract][Full Text] [Related]
16. Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes.
Sun S; Zhang X; Xu M; Zhang F; Tian F; Cui J; Xia Y; Liang C; Zhou S; Wei H; Zhao H; Wu G; Xu B; Liu X; Yang G; Wang Q; Zhang L; Gong Y; Shao C; Zou Y
Cell Death Dis; 2019 Mar; 10(4):274. PubMed ID: 30894513
[TBL] [Abstract][Full Text] [Related]
17. Allicin ameliorates imiquimod-induced psoriasis-like skin inflammation via disturbing the interaction of keratinocytes with IL-17A.
Zhang L; Ma X; Shi R; Zhang L; Zhao R; Duan R; Qin Y; Gao S; Li X; Duan J; Li J
Br J Pharmacol; 2023 Mar; 180(5):628-646. PubMed ID: 36355777
[TBL] [Abstract][Full Text] [Related]
18. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
19. Piperine ameliorates psoriatic skin inflammation by inhibiting the phosphorylation of STAT3.
Lu H; Gong H; Du J; Gao W; Xu J; Cai X; Yang Y; Xiao H
Int Immunopharmacol; 2023 Jun; 119():110221. PubMed ID: 37121114
[TBL] [Abstract][Full Text] [Related]
20. Genistein suppresses psoriasis-related inflammation through a STAT3-NF-κB-dependent mechanism in keratinocytes.
Wang A; Wei J; Lu C; Chen H; Zhong X; Lu Y; Li L; Huang H; Dai Z; Han L
Int Immunopharmacol; 2019 Apr; 69():270-278. PubMed ID: 30743203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
